U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H14N2O6
Molecular Weight 258.228
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of THYMINE ARABINOSIDE

SMILES

CC1=CN([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)C(=O)NC1=O

InChI

InChIKey=DWRXFEITVBNRMK-JAGXHNFQSA-N
InChI=1S/C10H14N2O6/c1-4-2-12(10(17)11-8(4)16)9-7(15)6(14)5(3-13)18-9/h2,5-7,9,13-15H,3H2,1H3,(H,11,16,17)/t5-,6-,7+,9-/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H14N2O6
Molecular Weight 258.228
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo.
2010-10
Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA.
2009-09-10
Substrate specificity of feline and canine herpesvirus thymidine kinase.
2008-08
Efficient and selective enzymatic acylation reaction: separation of furanosyl and pyranosyl nucleosides.
2008-07-18
Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
2008
N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.
2006-12-28
Bromovinyl-deoxyuridine: A selective substrate for mitochondrial thymidine kinase in cell extracts.
2006-05-26
3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.
2006-02-15
The effect of a methyl or 2-fluoroethyl substituent at the N-3 position of thymidine, 3'-fluoro-3'-deoxythymidine and 1-beta-D-arabinosylthymine on their antiviral and cytostatic activity in cell culture.
2006
Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides.
2005-12-15
Altered deoxyribonucleotide pools in T-lymphoblastoid cells expressing the multisubstrate nucleoside kinase of Drosophila melanogaster.
2005-08
Dexamethasone inhibits the HSV-tk/ ganciclovir bystander effect in malignant glioma cells.
2005-04-02
Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase.
2004-03-19
Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides, and 2'-fluoro-arabinofuranosyl nucleosides.
2004
Lipid-mediated protein delivery of suicide nucleoside kinases.
2003-10-15
Thymidine and thymidine-5'-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase.
2003-09-15
Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
2003-02
Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol.
2001-11-23
Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors.
2001-05-21
2'-O-Acyl/alkyl-substituted arabinosyl nucleosides as inhibitors of human mitochondrial thymidine kinase.
2001-03-15
Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.
2001-02
Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.
1999-10
Efficacy of select antivirals against Cryptosporidium parvum in vitro.
1998-11-01
Anti-herpesvirus activity profile of 4'-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-beta-D-2'-fluoro-4'-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus.
1998-08
Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
1997-08
Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds.
1995-07
Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.
1995-04
Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides.
1989-02
Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells.
1988-07
7-Aminoquinolines. A novel class of agents active against herpesviruses.
1988-07
Comparison of susceptibilities of varicella-zoster virus and herpes simplex viruses to nucleoside analogs.
1986-03
Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus.
1986-03
In vitro and in vivo antiviral activity of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) and related compounds.
1984-06
Antiherpes activity of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil and some other 5-substituted uracil arabinosyl nucleosides in two different cell lines.
1983-09
Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate.
1982-09
Inhibitory effects of antiherpesviral thymidine analogs against varicella-zoster virus.
1982-02
In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
1982-01
Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases.
1981-09
Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.
1981-07
Antiherpesviral activity and inhibitory action on cell growth of 5-alkenyl derivatives of 1-beta D-arabinofuranosyluracil.
1980-06
Relative potencies of different anti-herpes agents in the topical treatment of cutaneous herpes simplex virus infection of athymic nude mice.
1979-11
In vitro antiherpesviral activity of 5-alkyl derivatives of 1-beta-D-arabinofuranosyluracil.
1979-08
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.
1979-06
Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides.
1979-01
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:09:51 GMT 2025
Edited
by admin
on Mon Mar 31 22:09:51 GMT 2025
Record UNII
NS9U4BEG7Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NSC-68929
Preferred Name English
THYMINE ARABINOSIDE
Common Name English
SPONGOTHYMIDIN
Common Name English
5-METHYLARABINOSYLURACIL
Common Name English
THYMINE, 1-.BETA.-D-ARABINOFURANOSYL-
Systematic Name English
ARABINOSYLTHYMINE
Common Name English
1-.BETA.-D ARABINOFURANOSYLTHYMINE
Common Name English
SPONGOTHYMIDINE
Common Name English
1-.BETA.-D-ARABINOFURANOSYLTHYMINE
Common Name English
2,4(1H,3H)-PYRIMIDINEDIONE, 1-.BETA.-D-ARABINOFURANOSYL-5-METHYL-
Systematic Name English
Code System Code Type Description
NSC
68929
Created by admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
PRIMARY
FDA UNII
NS9U4BEG7Y
Created by admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
PRIMARY
PUBCHEM
65049
Created by admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
PRIMARY
CAS
605-23-2
Created by admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
PRIMARY
ECHA (EC/EINECS)
210-083-7
Created by admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
PRIMARY
EPA CompTox
DTXSID201194189
Created by admin on Mon Mar 31 22:09:51 GMT 2025 , Edited by admin on Mon Mar 31 22:09:51 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY